7MM Digital Therapeutics for Diabetes Market Size, Share & Forecast (2025–2033)
The 7MM Digital Therapeutics for Diabetes Market Size was valued at approximately USD 961.09 million in 2024 and is projected to reach USD 2,578.46 million by 2033, growing at a CAGR of 11.7% during the forecast period. This growth is driven by the rising adoption of software-driven, evidence-based interventions that manage and treat diabetes through digital platforms. These therapeutics leverage mobile apps, wearable devices, and cloud-based systems to deliver personalized, real-time behavioral and clinical support, ultimately improving outcomes and preventing complications.
For Sample Report
https://www.datamintelligence.com/download-sample/7mm-digital-therapeutics-for-diabetes-market
Key Developments
Integration of Artificial Intelligence (AI): AI is increasingly being integrated into digital therapeutics to analyze patient data and deliver customized interventions. This enhances glycemic control and patient engagement.
Launch of Byram Connect: In February 2025, Byram Healthcare introduced ByramConnect, a digital health program powered by the Welldoc app. It provides personalized insights based on six health dimensions for individuals managing type 1 or type 2 diabetes.
Eversense 365 CGM System: In October 2024, Ascensia Diabetes Care launched Eversense 365, a one-year continuous glucose monitoring system developed by Senseonics. This innovation offers consistent and accurate glucose tracking with fewer disruptions.
Market Trends
Advancements in Wearable Technology: The adoption of continuous glucose monitoring (CGM) devices integrated with digital platforms is rising. These tools enable real-time feedback and decision-making for patients and clinicians.
Personalized Digital Health Programs: Platforms that combine health data analytics and behavioral coaching are gaining traction. These tools enhance user compliance and provide tailored support for managing diabetes and related conditions.
Market Segments
By Product Type:
Software Solutions
Mobile Applications
Web-Based Solutions
Hardware Solutions
Wearable Devices
Continuous Glucose Monitors
Others
By Application:
Type 1 Diabetes
Type 2 Diabetes
Pre-Diabetes
By End-User:
Hospitals
Specialty Clinics
Homecare Settings
Others
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Competitive Landscape and Key Players
Noom, Inc.
Teladoc Health
Omada Health
WellDoc
Biofourmis
Better Therapeutics
Ascensia Diabetes Care
Senseonics Holdings, Inc.
About Us
DataM Intelligence is a global market intelligence and consulting firm that delivers actionable insights and deep industry analysis. The company specializes in comprehensive market reports across healthcare, technology, and other critical sectors to support informed business decisions.
Contact Us
DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: www.datamintelligence.com
Comments
Post a Comment